✦ LIBER ✦

Phase II feasibility study of high dose epirubicin plus etoposide and cisplatin (HDEEC) regimen in small cell lung cancer

✍ Scribed by Rafael Rosell; Juan Carles; Albert Abad; Jose M. Jimeno; Isabel Moreno; Agustin Barnadas; Nuria Ribelles; Nassir Haboubi

Publisher: Springer US
Year: 1992
Tongue: English
Weight: 472 KB
Volume: 10
Category: Article
ISSN: 0167-6997
DOI: 10.1007/bf00873130

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Etoposide versus etoposide plus high-dos

Etoposide versus etoposide plus high-dose cisplatin in the management of advanced non-small cell lung cancer: Results of a prospective randomized fonicap trial

✍ Professor Riccardo Rosso; Franco Salvati; Andrea Ardizzoni; Corrado Gallo Curcio 📂 Article 📅 1990 🏛 John Wiley and Sons 🌐 English ⚖ 568 KB

Phase II trial of etoposide and cisplati

Phase II trial of etoposide and cisplatin for refractory small cell lung cancer: A cancer and leukemia group B study

✍ Graziano, Stephen L. ;Lee, Kewchang ;Propert, Kathleen J. ;Tinsley, Roger ;Hayes 📂 Article 📅 1990 🏛 John Wiley and Sons 🌐 English ⚖ 466 KB 👁 1 views

## Abstract A phase II trial of etoposide and cisplatin for patients with previously treated small cell lung cancer was carried out by CALGB from June 1983 to May 1984. Thirty‐five evaluable patients who had failed one prior chemotherapy regimen were treated with etoposide 80 mg/m^2^ and cisplatin

Phase II study of a 72-h concurrent cont

Phase II study of a 72-h concurrent continuous infusion of cisplatin and etoposide in advanced non-small-cell lung cancer

✍ Hiroshi Saito; Kaoru Shimokata; Masashi Yamamoto; Hideo Saka; Shuzo Sakai; Hideh 📂 Article 📅 1993 🏛 Springer 🌐 English ⚖ 331 KB

A phase II trial of cisplatin and prolon

A phase II trial of cisplatin and prolonged administration of oral etoposide in extensive-stage small cell lung cancer

✍ Patrick B. Murphy; John D. Hainsworth; F. Anthony Greco; Kenneth R. Hande; Russe 📂 Article 📅 1992 🏛 John Wiley and Sons 🌐 English ⚖ 582 KB

Phase II study of high-dose aclarubicin

Phase II study of high-dose aclarubicin in previously treated patients with small-cell lung cancer

✍ Peter Buhl Jensen; Susanne Kornum Larsen; Irene Stilbo 📂 Article 📅 1992 🏛 Springer 🌐 English ⚖ 230 KB

High-dose cisplatin and mitomycin C in a

High-dose cisplatin and mitomycin C in advanced non-small cell lung cancer: a phase II study of the Northern California Oncology Group

✍ David R. Gandara; Edith A. Perez; Howard Wold; Vincent Caggiano; Mary Malec; Dav 📂 Article 📅 1990 🏛 Springer 🌐 English ⚖ 594 KB